(NASDAQ: OMIC) Singular Genomics Systems's forecast annual revenue growth rate of -19.68% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 4.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.08%.
Singular Genomics Systems's revenue in 2024 is $2,490,000.On average, 1 Wall Street analysts forecast OMIC's revenue for 2024 to be $148,185,940, with the lowest OMIC revenue forecast at $148,185,940, and the highest OMIC revenue forecast at $148,185,940.
In 2025, OMIC is forecast to generate $533,469,384 in revenue, with the lowest revenue forecast at $533,469,384 and the highest revenue forecast at $533,469,384.